BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 9579714)

  • 1. Experimental evaluation of roxithromycin combined with dapsone or sulphamethoxazole on Pneumocystis carinii and Toxoplasma gondii dual infections in a rat model.
    Brun-Pascaud M; Chau F; Derouin F; Girard PM
    J Antimicrob Chemother; 1998 Mar; 41 Suppl B():57-62. PubMed ID: 9579714
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug evaluation of concurrent Pneumocystis carinii, Toxoplasma gondii, and Mycobacterium avium complex infections in a rat model.
    Brun-Pascaud M; Rajagopalan-Levasseur P; Chau F; Bertrand G; Garry L; Derouin F; Girard PM
    Antimicrob Agents Chemother; 1998 May; 42(5):1068-72. PubMed ID: 9593128
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Experimental evaluation of combined prophylaxis against murine pneumocystosis and toxoplasmosis.
    Brun-Pascaud M; Chau F; Simonpoli AM; Girard PM; Derouin F; Pocidalo JJ
    J Infect Dis; 1994 Sep; 170(3):653-8. PubMed ID: 8077724
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination of PS-15, epiroprim, or pyrimethamine with dapsone in prophylaxis of Toxoplasma gondii and Pneumocystis carinii dual infection in a rat model.
    Brun-Pascaud M; Chau F; Garry L; Jacobus D; Derouin F; Girard PM
    Antimicrob Agents Chemother; 1996 Sep; 40(9):2067-70. PubMed ID: 8878582
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In-vitro activity of atovaquone, sulphamethoxazole and dapsone alone and combined with inhibitors of dihydrofolate reductase and macrolides against Pneumocystis carinii.
    Cirioni O; Giacometti A; Scalise G
    J Antimicrob Chemother; 1997 Jan; 39(1):45-51. PubMed ID: 9044027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A pilot study on the efficacy of epiroprim against developmental stages of Toxoplasma gondii and Pneumocystis carinii in animal models.
    Mehlhorn H; Dankert W; Hartman PG; Then RL
    Parasitol Res; 1995; 81(4):296-301. PubMed ID: 7624286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In-vitro and in-vivo activities of roxithromycin in combination with pyrimethamine or sulphadiazine against Toxoplasma gondii.
    Romand S; Bryskier A; Moutot M; Derouin F
    J Antimicrob Chemother; 1995 Jun; 35(6):821-32. PubMed ID: 7559193
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary prophylaxis for Pneumocystis carinii pneumonia: a randomized trial comparing cotrimoxazole, aerosolized pentamidine and dapsone plus pyrimethamine.
    Mallolas J; Zamora L; Gatell JM; Miró JM; Vernet E; Valls ME; Soriano E; SanMiguel JG
    AIDS; 1993 Jan; 7(1):59-64. PubMed ID: 8442918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dapsone-pyrimethamine compared with aerosolized pentamidine as primary prophylaxis against Pneumocystis carinii pneumonia and toxoplasmosis in HIV infection. The PRIO Study Group.
    Girard PM; Landman R; Gaudebout C; Olivares R; Saimot AG; Jelazko P; Gaudebout C; Certain A; Boué F; Bouvet E
    N Engl J Med; 1993 May; 328(21):1514-20. PubMed ID: 8479488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipophilic antifolates as agents against opportunistic infections. 1. Agents superior to trimetrexate and piritrexim against Toxoplasma gondii and Pneumocystis carinii in in vitro evaluations.
    Piper JR; Johnson CA; Krauth CA; Carter RL; Hosmer CA; Queener SF; Borotz SE; Pfefferkorn ER
    J Med Chem; 1996 Mar; 39(6):1271-80. PubMed ID: 8632434
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and antiparasitic and antitumor activity of 2, 4-diamino-6-(arylmethyl)-5,6,7,8-tetrahydroquinazoline analogues of piritrexim.
    Rosowsky A; Papoulis AT; Forsch RA; Queener SF
    J Med Chem; 1999 Mar; 42(6):1007-17. PubMed ID: 10090784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lack of activity of artemether for prophylaxis and treatment of Toxoplasma gondii and Pneumocystis carinii infections in rat.
    Brun-Pascaud M; Chau F; Derouin F; Girard PM
    Parasite; 1996 Jun; 3(2):187-9. PubMed ID: 8758556
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synergistic combinations of Ro 11-8958 and other dihydrofolate reductase inhibitors with sulfamethoxazole and dapsone for therapy of experimental pneumocystosis.
    Walzer PD; Foy J; Steele P; White M
    Antimicrob Agents Chemother; 1993 Jul; 37(7):1436-43. PubMed ID: 8363372
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of Pneumocystis carinii pneumonia and of cerebral toxoplasmosis by roxithromycin in HIV-infected patients.
    Durant J; Hazime F; Carles M; Pechere JC; Dellamonica P
    Infection; 1995; 23 Suppl 1():S33-8. PubMed ID: 7782114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Altered trimethoprim-sulfamethoxazole ratios for prophylaxis and treatment of Toxoplasma gondii and Pneumocystis carinii dual infections in rat model.
    Brun-Pascaud M; Chau F; Garry L; Farinotti R; Derouin F; Girard PM
    J Acquir Immune Defic Syndr Hum Retrovirol; 1996 Nov; 13(3):201-7. PubMed ID: 8898664
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relative potency of 10 drugs with anti-Pneumocystis carinii activity in an animal model.
    Hughes WT; Killmar JT; Oz HS
    J Infect Dis; 1994 Oct; 170(4):906-11. PubMed ID: 7930735
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activity of epiroprim (Ro 11-8958), a dihydrofolate reductase inhibitor, alone and in combination with dapsone against Toxoplasma gondii.
    Chang HR; Arsenijevic D; Comte R; Polak A; Then RL; Pechère JC
    Antimicrob Agents Chemother; 1994 Aug; 38(8):1803-7. PubMed ID: 7986011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-Toxoplasma effects of dapsone alone and combined with pyrimethamine.
    Derouin F; Piketty C; Chastang C; Chau F; Rouveix B; Pocidalo JJ
    Antimicrob Agents Chemother; 1991 Feb; 35(2):252-5. PubMed ID: 2024957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of experimental Toxoplasma gondii infection by clarithromycin-based combination therapy with minocycline or pyrimethamine.
    Alder J; Hutch T; Meulbroek JA; Clement JC
    J Acquir Immune Defic Syndr (1988); 1994 Nov; 7(11):1141-8. PubMed ID: 7932081
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of experimental Pneumocystis carinii infection by combination of clarithromycin and sulphamethoxazole.
    Alder J; Mitten M; Shipkowitz N; Hernandez L; Hui YH; Marsh K; Clement J
    J Antimicrob Chemother; 1994 Feb; 33(2):253-63. PubMed ID: 8182006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.